Cargando…
The Intricate Interplay between the ZNF217 Oncogene and Epigenetic Processes Shapes Tumor Progression
SIMPLE SUMMARY: The ZNF217 oncogene promotes progression, pluripotency and resistance to therapy in different types of cancer and is associated with increased risk of metastasis. High ZNF217 expression levels are a biomarker of poor prognosis in several cancers. Therapies targeting ZNF217 could be p...
Autores principales: | Fahmé, Pia, Ramadan, Farah, Le, Diep Tien, Thi, Kieu-Oanh Nguyen, Ghayad, Sandra E., Hussein, Nader, Diaz, Chantal, Croset, Martine, Clézardin, Philippe, Cohen, Pascale A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776013/ https://www.ncbi.nlm.nih.gov/pubmed/36551531 http://dx.doi.org/10.3390/cancers14246043 |
Ejemplares similares
-
Exploring the Significance of the Exon 4-Skipping Isoform of the ZNF217 Oncogene in Breast Cancer
por: Bellanger, Aurélie, et al.
Publicado: (2021) -
Non-coding RNA in rhabdomyosarcoma progression and metastasis
por: Ramadan, Farah, et al.
Publicado: (2022) -
ZNF217 confers resistance to the pro-apoptotic signals of paclitaxel and aberrant expression of Aurora-A in breast cancer cells
por: Thollet, Aurélie, et al.
Publicado: (2010) -
MiR-203 Suppresses ZNF217 Upregulation in Colorectal Cancer and Its Oncogenicity
por: Li, Zewu, et al.
Publicado: (2015) -
Retraction: MiR-203 Suppresses ZNF217 Upregulation in Colorectal Cancer and Its Oncogenicity
Publicado: (2020)